SRZN · Surrozen, Inc./DE
Market Cap
$263.51M
Shares
11.75M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$22.02
Open$22.28
Day$21.45–22.62
52W close$11.36–34.13
Avg vol 30d258K
Short int1.3M · 10.7% float · 4.8d
Short vol70%
Last earningsMar 22, 2023
DataDec 2023–Aug 2026
Filing10-Q · Aug 6
Raw chart and full-history price indicators begin at the captured split on Dec 14, 2023; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−5%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
47%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
−21%
trailing
YTD return
−3%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $23 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
+12% holders QoQ · +26 funds added
Insider flow
Distributing
Net -$6.9M over 90 days · 100% sells
Short interest
Rising
10.66% of float · ▲ +8.9% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
−67%
Y/Y
EPS growth
−49%
Y/Y
Free cash flow
$-30.4M
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−44%
past year
ATR
7.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−5%
Neutral
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
47%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $23 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
+12% holders QoQ · +26 funds added
Insider flow
Distributing
Net -$6.9M over 90 days · 100% sells
Short interest
Rising
10.66% of float · ▲ +8.9% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $11
Now $22 · 47%
Range high $34
vs 200-day avg -8%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SRZN
this stock
Surrozen, Inc./DE
|
$263.51M | -2.6% | -67.4% | — | 10.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.1% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +3.5% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.3% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.51B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Dec 14, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SRZN | -8.1% | +1.1% | -20.6% | -0.9% | -2.6% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -8.6% | -0.1% | -33.9% | -3.5% | -15.1% |
Key facts
CIK
1824893
CUSIP
86889P208
13F (30d)
75 filings
72 filers
Visit website
Investor relations